Structure-based characterization of novel TRPV5 inhibitors
- University of Pennsylvania, United States
- New Jersey Medical School, Rutgers University, United States
- Icahn School of Medicine at Mount Sinai, United States
Abstract
Transient receptor potential vanilloid 5 (TRPV5) is a highly calcium selective ion channel that acts as the rate-limiting step of calcium reabsorption in the kidney. The lack of potent, specific modulators of TRPV5 has limited the ability to probe the contribution of TRPV5 in disease phenotypes such as hypercalcemia and nephrolithiasis. Here, we performed structure-based virtual screening (SBVS) at a previously identified TRPV5 inhibitor binding site coupled with electrophysiology screening and identified three novel inhibitors of TRPV5, one of which exhibits high affinity, and specificity for TRPV5 over other TRP channels, including its close homologue TRPV6. Cryo-electron microscopy of TRPV5 in the presence of the specific inhibitor and its parent compound revealed novel binding sites for this channel. Structural and functional analysis have allowed us to suggest a mechanism of action for the selective inhibition of TRPV5 and lay the groundwork for rational design of new classes of TRPV5 modulators.
Data availability
The cryo-EM density maps and atomic coordinates of all structures presented in the text will be deposited into the Electron Microscopy Data Bank and Protein Data Bank under the following access codes: ZINC9155420-bound TRPV5 (PDB: 6PBF, EMB-20292); ZINC17988990-bound TRPV5 (PDB: 6PBE, EMB-20291).
-
ZINC9155420-bound TRPV5 in nanodiscsElectron Microscopy Data Bank, EMD-20292.
-
ZINC17988990-bound TRPV5 in nanodiscsElectron Microscopy Data Bank, EMD-20291.
Article and author information
Author details
John Smith Del Rosario
Aysenur Torun Yazici
Vera Y Moiseenkova-Bell
Funding
National Institute of General Medical Sciences (R01GM103899)
- Vera Y Moiseenkova-Bell
National Institute of General Medical Sciences (R01GM129357)
- Vera Y Moiseenkova-Bell
National Institute of General Medical Sciences (R01GM093290)
- Tibor Rohacs
National Institute of General Medical Sciences (R01GM131048)
- Tibor Rohacs
National Institute of Neurological Disorders and Stroke (R01NSNS055159)
- Tibor Rohacs
National Science Foundation (ACI-1053575)
- Marta Filizola
National Science Foundation (MCB080077)
- Marta Filizola
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2019, Hughes et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,664
- views
-
- 609
- downloads
-
- 56
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Citations by DOI
-
- 56
- citations for umbrella DOI https://doi.org/10.7554/eLife.49572
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Structure-based characterization of novel TRPV5 inhibitors
eLife 8:e49572.
https://doi.org/10.7554/eLife.49572
